Gilead Sciences

Gilead Sciences is a biopharmaceutical company that develops and markets innovative therapies in virology and oncology. The company’s portfolio includes groundbreaking antiviral drugs for HIV, hepatitis B and C, and emerging treatments for cancer. Gilead distinguishes itself by pursuing bold scientific ambitions and translating disruptive research into life‑saving medicines, while also addressing health inequities and improving access to care. Its culture emphasizes empowering scientists and employees to tackle global health challenges, fostering collaboration and a shared commitment to improving patient outcomes worldwide.